China Resources Sanjiu Medical & Pharmaceutical Co Ltd SZSE:000999:
SAYS CO PLANS TO INVEST UP TO 10 BILLION YUAN ($1.41 billion) IN WEALTH MANAGEMENT PRODUCTS
($1 = 7.1043 Chinese yuan renminbi)
China Resources Sanjiu Medical & Pharma To Invest In Wealth Management Products
Earlier from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Class A
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue up 4.99% but net profit down 24.31% as Tasly acquisition reshapes business
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue and profit declined, but asset growth and Tasly integration drive future potential
- China Resources Sanjiu Medical & Pharmaceutical Co: Revenue and net profit surged on strong CHC and prescription drug growth, with a 50% payout
- China Resources Sanjiu Medical & Pharmaceutical Co: Net profit jumped 23.19% year-over-year, with strategic M&A and innovation fueling growth